San Diego-based mostly Viking Therapeutics marked alone as a significant competitor during the weight loss drug current market in February after revealing promising details from a mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As well as in Ma